Seoul National University Hospital
Seoul, 03080, South Korea
NCT Number: NCT06123923
Purpose: We determined the incidence, etiology, and longitudinal trends of vitreoretinal diseases necessitating pars plana vitrectomy (PPV) in the pediatric and adolescent population.
Design: This was a nationwide, population-based cohort study, utilizing data from the Korean National Health Claims database spanning from 2009 to 2020.
Given the retrospective design of the study and the anonymized nature of the data, the requirement for informed consent was waived.
Methods: All pediatric and adolescent patients (under 20 years of age) who underwent PPV across the Korean population were included. The cumulative incidence of PPV was estimated from 2009 to 2020, with 2009 to 2011 as the washout period. The annual trends of PPV incidence, the proportion of each etiology, and comorbidity were estimated based on sex and specific age groups.
Looking for future studies?
Notify Me0 year–19 year
All sexes
Observational
Seoul, 03080, South Korea
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
no intervention, just retrospective observation
Time frame: 2009-2020
vitreoretinal surgeries that had already performed during the retrospective study period
Seoul National University Hospital
Other
Contemporary Patterns and Underlying Causes of Vitrectomy in Pediatric and Adolescent Patients: A Nationwide, Population-Based Analysis
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT02477605
Vitreoretinal Disease
Fort Worth, Texas, United States
View Trial DetailsNCT07298174
Age - Related Macular Degeneration (AMD), Best Disease
View Trial DetailsNCT06294613
Vitreoretinal Disease
Ghent, East Flanders, Belgium
View Trial DetailsNCT06429969
Vitreoretinal Disease
Wuhan, Hubei, China
View Trial Details